Brazil Pension Fund Crackdown After Banco Master Collapse Raises Investment Concerns 
Advantest Stock Falls on Weak Outlook Despite Strong AI-Driven Results 
Toyota Global Vehicle Sales Decline in March Amid RAV4 Transition and Middle East Slowdown 
Sun Pharma to Acquire Organon in $11.75 Billion Deal to Boost Global Women’s Health Portfolio 
Nomura Shares Drop After Profit Miss Despite Strong Revenue Growth 
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds 
Chinese Chip Stocks Surge on AI Boom and Domestic Tech Push 
Australia Targets Meta, Google, and TikTok With New News Payment Tax Proposal 
Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations 
U.S. Budget Airlines Seek $2.5 Billion Government Aid Amid Rising Jet Fuel Costs 
OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO 
Kia Cuts EV Prices in Europe as Chinese Carmakers Intensify Competition 
DeepSeek V4 Launch Signals China’s Growing AI Independence with Huawei Chips 
Brazil Blocks Prediction Market Platforms, Tightens Derivatives Trading Rules 
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals 
Google Secures Pentagon AI Deal for Classified Projects 
U.S. Warns Allies Over Alleged Chinese AI IP Theft Linked to DeepSeek 
CARLSBAD, Calif., May 08, 2017 -- Alphatec Holdings, Inc. (Nasdaq:ATEC) (the “Company”), the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today that the Company plans to release its first quarter 2017 financial results on Thursday, May 11, 2017 after the market closes.
The Company will hold a conference call on Thursday, May 11, 2017 at 1:30 p.m. PT / 4:30 p.m. ET to discuss the results. The dial-in numbers are (877) 556-5251 for domestic callers and (720) 545-0036 for international callers. The conference ID number is 19608962. A live webcast of the conference call will be available online from the investor relations page of the Company's corporate website at www.alphatecspine.com.
A replay of the webcast will remain available on the Company’s website, www.alphatecspine.com, until the Company releases its second quarter 2017 financial results. In addition, a telephonic replay of the call will be available until May 18, 2017. The replay dial-in numbers are (855) 859-2056 for domestic callers and (404) 537-3406 for international callers. Please use the replay conference ID number 19608962.
About Alphatec Holdings, Inc.
Alphatec Holdings, Inc., through its wholly-owned subsidiary of Alphatec Spine, Inc., is a medical device company that designs, develops and markets spinal fusion technology products and solutions for the treatment of spinal disorders associated with disease and degeneration, congenital deformities and trauma. The Company's mission is to improve lives by delivering advancements in spinal fusion technologies. The Company markets products in the U.S. via independent sales agents and a direct sales force.
Additional information can be found at www.alphatecspine.com.
Investor/Media Contact: Nick Laudico or Zack Kubow The Ruth Group (646) 536-7000 [email protected] Company Contact: Jeff Black Executive Vice President and CFO Alphatec Holdings, Inc. (760) 431-9286
